Locoregional extension assessment of breast cancer and neoadjuvant chemotherapy: Place of contrast-enhanced mammography

This case illustrates the possibility of performing contrast-enhanced mammography in the two indications validated by the French national authority for health (Haute Autorite de sante) in the absence of MRI contraindication: locoregional extension assessment of breast cancer to re-evaluate the lesion size of a multifocal lesion, and evaluation before and after neoadjuvant chemotherapy for conservative treatment in case of good response to neoadjuvant chemotherapy. The main advantages for the patients are the reduction of the delay of access to the examination, the shorter time of realization and the better acceptability of the examination. For the radiosurgery team, contrast-enhanced mammography has the advantage of being easy to read and interpret. (c) 2023 Elsevier Masson SAS. All rights reserved.